SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014859
Filing Date
2022-08-04
Accepted
2022-08-04 17:06:32
Documents
76
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dawn-20220630.htm   iXBRL 10-Q 3459305
2 EX-10.1 dawn-ex10_1.htm EX-10.1 345217
3 EX-31.1 dawn-ex31_1.htm EX-31.1 15901
4 EX-31.2 dawn-ex31_2.htm EX-31.2 15943
5 EX-32.1 dawn-ex32_1.htm EX-32.1 9940
6 EX-32.2 dawn-ex32_2.htm EX-32.2 11162
7 GRAPHIC img11719290_0.jpg GRAPHIC 349438
  Complete submission text file 0000950170-22-014859.txt   12287863

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dawn-20220630_cal.xml EX-101.CAL 41277
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dawn-20220630_lab.xml EX-101.LAB 523574
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dawn-20220630.xsd EX-101.SCH 71338
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dawn-20220630_def.xml EX-101.DEF 331736
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dawn-20220630_pre.xml EX-101.PRE 448490
70 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20220630_htm.xml XML 2003762
Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40431 | Film No.: 221137634
SIC: 2834 Pharmaceutical Preparations